Machine Medicine
Entrepreneur First '17London, GB · Founded 2017 · 2 known investors
Machine Medicine develops Kelvin, a system that records patient movement on video and applies pose estimation to quantify it. Clinicians and researchers use it on standard devices to administer, score, and compare motor assessments, producing repeatable measurements of symptoms such as tremor and bradykinesia.
Also known as Machine Medicine Technologies · Machine Medicine Technologies Limited
Founders & leadership
Machine Medicine was founded in 2017 by Jonathan O'Keeffe and Georgiana Petria.
Investors · 2
Company profile
researched Aug 2026Machine Medicine Technologies is a London-based software developer building Kelvin, a platform for capturing and modelling "neurodata" — video, audio, image, sensor and text recordings of patient behaviour — and turning it into quantified measures of brain function and behaviour.
The Kelvin platform is organised into four components. Kelvin Clinic is used by clinicians to collect data during in-clinic visits through structured assessments and integrated tools. Kelvin Reach allows study participants to record data at home with guided, step-by-step instructions and automated quality control. Kelvin Cloud lets users deploy standard medical forms or custom assignments for multi-modal capture, and review, compare and share results on a single platform. Kelvin Cortex provides data scientists with secure, privacy-first tooling to run large-scale analyses on subject data and to build production models that integrate with the rest of the Kelvin ecosystem.
Stated platform capabilities include no-code customisation of capture forms, consistent capture across Android and iOS phones and tablets in home or clinical settings, AI validation of capture conditions before each session with real-time anomaly monitoring, centralised multi-site study and subject-care management, privacy-preserving cohort analytics, and end-to-end automation from capture through analysis and reporting. An earlier company description characterises Kelvin as a platform for recording, scoring, storing and analysing video of Parkinson's patients during motor assessment, using pose estimation to track movement to fingertip level and to deliver objective metrics of core symptoms such as tremor and bradykinesia, addressing subjectivity, reproducibility and rater drift in motor assessment.
Business model
Machine Medicine supplies a software platform (Kelvin) to clinicians, researchers, medical device companies and pharmaceutical companies for capturing and analysing neurodata. The platform is delivered as mobile applications for in-clinic and at-home data capture (distributed through the Play Store and App Store) alongside cloud-based review, study management and analytics products, with prospective customers directed to schedule a demonstration rather than self-serve sign-up. The sources do not disclose pricing or contract structures.
Not stated in the sources. A third-party data aggregator estimates annual revenue of approximately $1,454,435 and revenue per employee of $86,000, but these are modelled estimates rather than disclosed figures.
Traction
Quantified traction is limited in the sources. A third-party aggregator lists 11-20 employees (with a departmental breakdown of nine employees across five departments: five in engineering and technical, one medical, one customer service; and a seniority breakdown of five entry-level, four manager and one C-suite), estimated annual revenue of about $1.45 million and an estimated valuation of about $4.7 million. The company states that clinicians, researchers, medical device and pharmaceutical companies use its tools, without naming customers.
Latest developments
Companies House lists the company as active as of records showing last accounts made up to 31 October 2025 and a confirmation statement dated 7 March 2026. The current website presents the Kelvin product line as four components — Clinic, Reach, Cloud and Cortex — framed around scalable neurodata capture and modelling for "Brain-Tech," a broader positioning than the earlier Parkinson's-specific motor-assessment description of the platform.
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
The company is described as a small London-based developer, categorised by one third-party data provider under medical equipment manufacturing with 11-20 employees and an estimated annual revenue of roughly $1.45 million and an estimated valuation of roughly $4.7 million (both figures are that provider's industry-average-based estimates rather than reported financials). The sources do not name competitors or provide market share information.
The material positions the platform around objective, device-agnostic measurement: pose-estimation-based quantification intended to reduce subjectivity, reproducibility problems and rater drift in motor assessment; consistent capture across Android and iOS phones and tablets in both home and clinic settings; no-code configuration of capture forms; automated pre-session validation of capture conditions and real-time anomaly detection; and an integrated path from capture through cloud review to privacy-preserving large-scale modelling.
Technology
Kelvin uses computer-vision pose estimation to track patient movement from standard video down to fingertip level and derive objective metrics for symptoms such as tremor and bradykinesia. Capture supports video, audio, image, sensor and text modalities on Android and iOS phones and tablets, with AI-based validation of capture conditions before each session and real-time anomaly monitoring. Kelvin Cortex provides secure, privacy-preserving tooling for large-scale cohort analysis and building production models that integrate with the platform. The company's web infrastructure is reported by a third-party scanner to include WordPress plugins (Jetpack, Shortcodes Ultimate), jQuery and related JavaScript libraries, Swiper, Survicate, PHP, reCAPTCHA, HSTS and HTTP/3.
Go-to-market
The company markets directly to clinicians, researchers, and medical device and pharmaceutical companies, with the website's primary call to action being to schedule a demonstration. Mobile applications for the Kelvin Clinic and Kelvin Reach products are distributed via the Google Play Store and the Apple App Store, and web entry points are provided for Kelvin Cloud and Kelvin Cortex.
Clinicians, researchers, medical device companies and pharmaceutical companies; end users of remote capture include study participants recording from home. Earlier descriptions focus on researchers and clinicians assessing people with Parkinson's disease.
Geography
The company is based in London, England, United Kingdom, and is registered there as a UK private limited company. No other locations are described in the sources. The company operates websites at machinemedicine.com and machinemedicine.io.
History
The company was incorporated in the UK as Machine Medicine Technologies Limited on 24 May 2017 (company number 10787420), registered as a private limited company with a nature of business of business and domestic software development. Its registered office is 3 Dartle Court, Dickens Estate, London SE16 4PX; a separate business address at Unit J305, The Biscuit Factory, 100 Drummond Road, London SE16 4DG is listed by a third-party data provider. Companies House records show the company as active, with last accounts made up to 31 October 2025 and a confirmation statement dated 7 March 2026. An earlier description of the company positions Kelvin primarily as a Parkinson's disease motor-assessment platform, while the current company website presents a broader "Brain-Tech" neurodata platform spanning clinic capture, remote capture, cloud review and large-scale modelling.
Risks & controversies
No controversies are reported in the sources. Data-quality caveats apply to the third-party aggregator profile: its revenue and valuation figures are explicitly described as estimates derived from industry averages, its funding table lists three entries dated 2023-08-14, 2024-02-01 and 2025-01-04 with unlabelled round values (13, 1, 20), no amounts and no linked articles, and elsewhere on the same page total funding is stated as "No funding," so the funding history there is internally inconsistent and unverifiable.
Compiled by commissioned research from 6 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
▸Research sources · 6
primary sources listed
- Machine Medicinemachinemedicine.com · web
6 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Machine Medicine do?
- London-based developer of Kelvin, a platform for capturing and analysing video-based neurodata for clinical and research use.
- Who founded Machine Medicine?
- Machine Medicine was founded by Jonathan O'Keeffe, Georgiana Petria in 2017.
- Who are Machine Medicine's investors?
- Machine Medicine's investors include Entrepreneur First, Meridian Health Ventures.
- Where is Machine Medicine headquartered?
- Machine Medicine is headquartered in London, GB.